SPY322.64-7.66 -2.32%
DIA267.58-5.23 -1.92%
IXIC10,632.99-330.65 -3.02%

Cowen & Co. Maintains Outperform on Amgen, Raises Price Target to $277

Cowen & Co. analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $253 to $277.

Benzinga · 12/20/2019 14:25

Cowen & Co. analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $253 to $277.